RecruitingNCT06924021

Age-Related Macular Degeneration Benchmark Imaging Dataset (ABID)

Sponsor

University of Wisconsin, Madison

Enrollment

1,000 participants

Start Date

May 12, 2025

Study Type

OBSERVATIONAL

Conditions

Age-Related Macular Degeneration

Summary

1000 participants from up to 25 international locations who are at least 50 years old with either healthy eyes or a diagnosis of Age-Related Macular Degeneration (AMD) will be consented to provide images of their eyes for a new dataset. This dataset is an important step in developing an Artificial Intelligence (AI) based screening tool for AMD.

Eligibility

Min Age: 50 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Retinal Imaging for people with age-related macular degeneration. The study is currently recruiting participants at 14 locations. People eligible for this study include aged 50 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERRetinal Imaging

Eligible participants will undergo one retinal imaging session of both eyes for the following: * Single field stereo color fundus photography (cFP) - pre and post dilation * Macular spectral domain-optical coherence tomography (SD-OCT)

Locations(14)

Bergstrom Eye Research LLC

Fargo, North Dakota, United States

Erie Retina Research

Erie, Pennsylvania, United States

Retina Foundation of the Southwest

Dallas, Texas, United States

Valley Retina Institute

McAllen, Texas, United States

Retina Consultants of Texas (Houston)

The Woodlands, Texas, United States

University of Utah - John A. Moran Eye Center

Salt Lake City, Utah, United States

University Station Eye Care Clinic

Madison, Wisconsin, United States

Charles Research Center

Buenos Aires, Argentina

Adelaide Eye and Retina Centre

Adelaide, Australia

Centre Hospialier Intercommunal de Paradis (Centre Monticelli Paradis)

Marseille, France

University of Bonn - Department of Ophthalmology

Bonn, Germany

Sankara Nethralaya, Medical Research Foundation

Chennai, Tamil Nadu, India

Aravind Eye Hospital

Chennai, Tamil Nadu, India

Aga Khan University

Karachi, Pakistan

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06924021

Related Trials

A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)

NCT0744022591 locations

The Effects of Disulfiram (Antabuse®) on Visual Acuity in Patients With Retinal Degeneration

NCT063198721 location

Identification of Molecular Signals in Vitreous Humor Associated With Suboptimal Response to Vascular Endothelial Growth Factor (VEGF) Inhibition in Neovascular Age-related Macular Degeneration (nAMD) Within a Clinical Trial Setting

NCT072492161 location

A First-In-Human Study of ARO-033 in Adult Participants

NCT076620961 location

Survival of Monocytes Collected From Patients With Atrophic AMD in Retinal Pigmented Epithelium Explants

NCT046970952 locations